Back to results
US 2024/0252561 A1Published application
Therapeutic pharmaceutical composition for bone and soft tissue tumors
AssigneeSurv BioPharma Inc.
InventorsKen-ichiro KOSAI, Satoshi NAGANO, Toshitaka FUTAGAWA
Life of this patent
Estimating the term…
Abstract
A method for treating a bone and soft tissue tumor, including administering a conditionally replicating adenovirus having a E1A gene under expression control of a Survivin promoter, to a subject in need thereof. A conditionally replicating adenovirus including a E1A gene under expression control of a Survivin promoter and the conditionally replicating adenovirus is not defective in a E3 region.
Claims21
1-15. (canceled)
A method for treating a bone and soft tissue tumor, comprising:
- administering a conditionally replicating adenovirus having a E1A gene under expression control of a Survivin promoter, to a subject in need thereof.
A conditionally replicating adenovirus having a ETA gene under expression control of a Survivin promoter,
- wherein the conditionally replicating adenovirus is not defective in a E3 region.
Dependencies are inferred from the claim text.